NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
14.47
+0.19 (1.33%)
Aug 18, 2026, 4:00 PM EDT - Market closed
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $496.67 million as of August 18, 2026. Its market cap has increased by 75.39% in one year.
Market Cap
496.67M
Enterprise Value
514.90M
1-Year Change
75.39%
Ranking
Category
Stock Price
$14.47
ChartMarket Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $496.67M, an increase of 26.29%. That is a compound annual growth rate of 4.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 496.67M | -3.42% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BrainsWay | 621.09M |
| Cytek Biosciences | 616.12M |
| Cerus | 598.53M |
| Delcath Systems | 591.61M |
| Tactile Systems Technology | 557.02M |
| ClearPoint Neuro | 472.82M |
| Sight Sciences | 453.93M |
| Senseonics Holdings | 424.58M |